会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Fatty acid esters of 8-substituted
10-[4-(hydroxyalkyl)piperazino]-10,11-dihydrodibenzo[b,f]thiepins
    • 8-取代的10- {8 4-(羟基烷基)哌嗪基{9-10,11-二氢二苯并{8b,f {9 thiepins)的脂肪酸酯
    • US3985750A
    • 1976-10-12
    • US490218
    • 1974-07-19
    • Miroslav ProtivaJiri JilekKarel SindelarJirina Metysova
    • Miroslav ProtivaJiri JilekKarel SindelarJirina Metysova
    • C07D313/12C07D337/14C07D409/04
    • C07D337/14C07D313/12
    • Fatty acid esters of 8-substituted 10-[4-(hydroxyalkyl)piperazino]-10,11-dihydrodibenzo[b,f]thiepins and oxepins having the formula ##SPC1##In which X is a sulfur or oxygen atom, R.sup.1 is a hydrogen, chloro, or trifluoromethyl radical, a lower alkyl radical having at most 5 carbon atoms, or a cycloalkyl radical having at least 3 and at most 8 carbon atoms, or an alkoxy or alkylthio radical the alkyl moiety of which has at most 4 carbon atoms, R.sup.2 is an alkyl radical having at least 5 and at most 17 carbon atoms, and n is 2, 3, or 4, and their salts with pharmaceutically acceptable inorganic and organic acids. The compounds have a high degree of neuroleptic activity and retain this activity for long periods after administration.Related fatty acid esters of 8-substituted 10-[4-(hydroxyalkyl)-piperazino]dibenzo[b,f]thiepins and oxepins having the formula ##SPC2##And fatty acid esters of 8-substituted 4-[4-(hydroxyalkyl)piperazino]thieno[2,3-b]-1-benzothiepins and oxepins having the formula ##SPC3##In which formulae X, R.sup.1, R.sup.2 and n each have the foregoing significance, are also included herein.
    • 8-取代的10- [4-(羟基烷基)哌嗪基] -10,11-二氢二苯并[b,f]硫蛋白和具有式IN的氧杂环丁烷的脂肪酸酯,其中X是硫或氧原子,R1是氢,氯 或三氟甲基,具有至多5个碳原子的低级烷基或具有至少3个且至多8个碳原子的环烷基,或其烷基部分具有至多4个碳原子的烷氧基或烷硫基,R 2 是具有至少5个且至多17个碳原子,n为2,3或4的烷基,以及它们与药学上可接受的无机酸和有机酸的盐。 这些化合物具有高度的精神安定性活性,并且在施用后长时间保留该活性。
    • 5. 发明授权
    • N-substituted 2-chloro-7-fluoro-10-piperazino-10,11-dihydrodibenzo (B,F)
thiepins and acid addition salts thereof
    • N-取代的2-氯-7-氟-10-哌嗪基-10,11-二氢二苯并(B,F)硫蛋白及其酸加成盐
    • US4678788A
    • 1987-07-07
    • US821992
    • 1986-01-24
    • Miroslav ProtivaJiri JilekIrena CervenaAntonin DlabacMartin ValcharJosef Pomykacek
    • Miroslav ProtivaJiri JilekIrena CervenaAntonin DlabacMartin ValcharJosef Pomykacek
    • A61K31/495A61P25/20C07D337/14C07D409/12C07D409/04
    • C07D409/12C07D337/14
    • N-substituted 2-chloro-7-fluoro-10-piperazino-10,11-dihydrodibenzo(b,f)thiepins are disclosed of the general formula I, ##STR1## in which R represents an aminocarbonyl, amino-oximinomethyl, 1,3-dioxolan-2-yl or 1,3-dioxan-2-yl, group and their addition salts with convenient organic and inorganic acids. These compounds are highly potent antidopaminergic, non-cataleptic neuroleptics of use in the treatment of schizophrenia. According to recent pharmacological assay results, the subject compounds are expected to be substantially free of the usual undesired extrapyramidal side effects. They can be obtained by common preparative methods from the respective starting compounds of formula III, IV or V, or also by appropriate interconversion reactions of other compounds of formula I. If required, the resulting bases are neutralized with suitable acids, preferably methanesulfonic, maleic or hydrochloric acid, to yield the corresponding addition salts that can be used in formulating proper dosage forms for pharmacological evaluation and therapeutical application.
    • N-取代的2-氯-7-氟-10-哌嗪基-10,11-二氢二苯并(b,f)thiepins公开了通式I,其中R表示氨基羰基,氨基 - 肟基甲基 ,1,3-二氧戊环-2-基或1,3-二恶烷-2-基,它们与方便的有机和无机酸的加成盐。 这些化合物是用于治疗精神分裂症的高效抗癌剂,非抗抑郁药治疗精神分裂症。 根据最近的药理学测定结果,本发明化合物预期基本上不含常见的不希望的锥体束外副作用。 它们可以通过相应的式III,IV或V的起始化合物的常规制备方法获得,或者也可以通过其它式I化合物的适当相互转化反应获得。如果需要,所得碱用合适的酸中和,优选甲磺酸,马来酸 或盐酸,以产生相应的加成盐,其可用于配制用于药理学评价和治疗应用的适当剂型。